Vuong Trieu - CHAIRMAN AND CEO, Director, 10%+ Owner at Oncotelic Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Issuer Symbol
OTLC on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Vuong Trieu since 04 Feb 2025

Holdings reported by Vuong Trieu for Oncotelic Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 93,388,297 $4,669,414 $0.0500 08 Jul 2025 Direct
Common Stock 16,780,384 $839,019 $0.0500 08 Jul 2025 By Autotelic, Inc.
Common Stock 6,872,529 $343,626 $0.0500 08 Jul 2025 By Spouse
Series A Convertible Preferred Stock 4,065 17 Nov 2025 Direct Com-mon Stock

Transactions reported by Vuong Trieu for Oncotelic Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.